Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use

Free access to a review on the challenges and limitations in the manufacturing and quality development of cell-based medicinal products, exclusively for RegMedNet members Despite a large number of cell-based medicinal products undergoing clinical trials, few have reached the market. Manufacturing and quality control are significant challenges and are discussed in the Regenerative Medicine (Volume 10 Issue 1) review ‘Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use’ by Paula Salmikangas et al.; current and former members and experts of the Committee for Advanced Therapies, EMA, London, UK. Click here to access this review for free,...